CA2478398A1 - Methods for identifying compounds that modulate enzymatic activity - Google Patents

Methods for identifying compounds that modulate enzymatic activity Download PDF

Info

Publication number
CA2478398A1
CA2478398A1 CA002478398A CA2478398A CA2478398A1 CA 2478398 A1 CA2478398 A1 CA 2478398A1 CA 002478398 A CA002478398 A CA 002478398A CA 2478398 A CA2478398 A CA 2478398A CA 2478398 A1 CA2478398 A1 CA 2478398A1
Authority
CA
Canada
Prior art keywords
extender
ptp
target
functionality
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002478398A
Other languages
English (en)
French (fr)
Inventor
Daniel A. Erlanson
Robert S. Mcdowell
Stig Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viracta Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/121,216 external-priority patent/US6998233B2/en
Application filed by Individual filed Critical Individual
Publication of CA2478398A1 publication Critical patent/CA2478398A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002478398A 2002-04-10 2003-02-26 Methods for identifying compounds that modulate enzymatic activity Abandoned CA2478398A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/121,216 2002-04-10
US10/121,216 US6998233B2 (en) 1998-06-26 2002-04-10 Methods for ligand discovery
US37703402P 2002-05-01 2002-05-01
US60/377,034 2002-05-01
US10/374,499 2003-02-25
US10/374,499 US7214487B2 (en) 1998-06-26 2003-02-25 Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
PCT/US2003/006217 WO2003087054A2 (en) 2002-04-10 2003-02-26 Methods for identifying compounds that modulate enzymatic activity

Publications (1)

Publication Number Publication Date
CA2478398A1 true CA2478398A1 (en) 2003-10-23

Family

ID=29255201

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002478398A Abandoned CA2478398A1 (en) 2002-04-10 2003-02-26 Methods for identifying compounds that modulate enzymatic activity

Country Status (6)

Country Link
US (2) US7214487B2 (https=)
EP (1) EP1497450A4 (https=)
JP (1) JP2006506947A (https=)
AU (2) AU2003216468B2 (https=)
CA (1) CA2478398A1 (https=)
WO (1) WO2003087054A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
PL229487B1 (pl) 2002-11-12 2018-07-31 Brigham & Womens Hospital Inc Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego
US7736911B2 (en) * 2004-04-15 2010-06-15 Albert Einstein College Of Medicine Of Yeshiva University Activity-based probes for protein tyrosine phosphatases
US8039194B2 (en) * 2008-01-08 2011-10-18 Internatinal Business Machines Corporation Photoacid generators for extreme ultraviolet lithography
CN102159540B (zh) 2008-07-21 2015-08-12 布赖汉姆妇女医院 与合成的β-1,6葡糖胺寡糖相关的方法和组合物
US8394922B2 (en) 2009-08-03 2013-03-12 Medarex, Inc. Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
CN102939110A (zh) 2010-04-21 2013-02-20 诺沃—诺迪斯克有限公司 蛋白质的选择性修饰
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
CN114853629B (zh) * 2021-02-03 2023-06-13 沈阳农业大学 一种二肽类化合物及其制备方法和应用
JP7805983B2 (ja) 2022-03-22 2026-01-26 アッヴィ・インコーポレイテッド ブルトン型チロシンキナーゼを分解するためのピリミジン

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367058A (en) * 1993-08-25 1994-11-22 Becton, Dickinson And Company Modified antibodies with increased affinity
US6998233B2 (en) * 1998-06-26 2006-02-14 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
US6919178B2 (en) * 2000-11-21 2005-07-19 Sunesis Pharmaceuticals, Inc. Extended tethering approach for rapid identification of ligands
CA2430234C (en) 2000-11-21 2008-02-12 Sunesis Pharmaceuticals, Inc. An extended tethering approach for rapid identification of ligands
MXPA04001000A (es) 2001-08-07 2004-06-25 Sunesis Pharmaceuticals Inc Mutantes de cisteina y metodos para detectar union de ligando a moleculas biologicas.
IL159983A0 (en) 2001-08-07 2004-06-20 Sunesis Pharmaceuticals Inc Disulfide and thiosulfonate ligands and libraries comprising these ligands
MXPA04004814A (es) 2001-11-21 2004-08-11 Sunesis Pharmaceuticals Inc Metodos para descubrir ligandos.

Also Published As

Publication number Publication date
US7214487B2 (en) 2007-05-08
US20040005632A1 (en) 2004-01-08
JP2006506947A (ja) 2006-03-02
AU2003216468A1 (en) 2003-10-27
EP1497450A4 (en) 2010-03-10
AU2008246264A1 (en) 2008-12-11
EP1497450A2 (en) 2005-01-19
WO2003087054A2 (en) 2003-10-23
US20080220536A1 (en) 2008-09-11
WO2003087054A3 (en) 2004-08-05
AU2003216468B2 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
US20080220536A1 (en) Methods for Identifying Compounds that Modulate Enzymatic Activities by Employing Covalently Bonded Target-Extender Complexes with Ligand Candidates
Lu et al. Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets
JP3836791B2 (ja) リガンドの迅速な同定のための拡張されたテザー化アプローチ
JP4391237B2 (ja) リガンド発見のための方法
Hameed et al. Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors
JP2013116121A (ja) リガンド発見のための方法
JP2005534286A (ja) キナーゼインヒビターの同定
CA2964644A1 (en) Compositions and methods for the inhibition of dishevelled proteins
Iannelli et al. Turning nonselective inhibitors of type I protein arginine methyltransferases into potent and selective inhibitors of protein arginine methyltransferase 4 through a deconstruction–reconstruction and fragment-growing approach
Iyamu et al. Mechanisms and inhibitors of nicotinamide N-methyltransferase
JP2005517184A (ja) Ｈｓｐ９０アクチベーターａｈａ１を伴う方法および組成物
van Geel et al. Detection of transglutaminase activity using click chemistry
CA2478395A1 (en) Methods for identifying allosteric sites
Tiemann et al. A Formylglycine‐Peptide for the Site‐Directed Identification of Phosphotyrosine‐Mimetic Fragments
Zhou Biochemical, Biophysical, Structural and Cellular Studies of Protein-Ligand Interaction: Insights on Early Drug Discovery Targeting PRMT5 and TEAD2
AYOOB et al. DESIGN, SYNTHESIS, MOLECULAR DOCKING OF NOVEL METHIMAZOLE DERIVATIVES AS PROMISING ANTITHYROID AGENTS.
Hayes Chemical inhibitors of protein-protein interactions involved in G protein-mediated signaling events as potential therapeutics
BIWEI DEVELOPING NOVEL CHEMICAL BIOLOGY TOOLS FOR INTERROGATION OF CELLULAR DRUG TARGETS AT MOLECULAR AND CELLULAR LEVELS
Kathman Inhibitors of the Ubiquitin Ligase Nedd4-1 Discovered by Covalent Fragment Screening
Koenig Probing the Mechanism of Binding and Recognition of Methylated Lysine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20140507